LifeMD, Inc. in 1 story
The narratives LFMD currently appears in, with its side and exposure in each.
Bull side
1 story- GLP-1 Eats Everything
LFMD in “GLP-1 Eats Everything”
FadingExposure: not rated yetAppetite suppression as a macro variable.
LifeMD can monetize growing GLP-1 demand through its direct-to-consumer telehealth weight-management platform and recurring clinical services.
Bear side
0 storiesNo bear-side stories for LFMD yet.